Study Overview
Let's Talk About It




The Time is Now
Mitapivat is a potential new therapy for the pain crises and anemia of sickle cell disease. There have already been smaller studies for mitapivat. Now it's time to move into a larger clinical trial — RISE UP, a phase 2/3 study.